Sleep Breath 2004; 8(1): 1-5
DOI: 10.1055/s-2004-822848
ORIGINAL ARTICLE

Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Inspired Oxygen Concentrations during Positive Pressure Therapy

Elizabeth A. Yoder1 , Kenneth Klann1 , Kingman P. Strohl1
  • 1Louis Stokes Cleveland DVA Medical Center, Medical Service, Center for Sleep Disorders Research, Case Western Reserve University, Cleveland, Ohio
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
17. März 2004 (online)

Objectives: This study examined the effects of various factors that might influence the fraction of oxygen in inspired air (FiO2) in a human and in a model system during nasal positive pressure treatments. Design and Methods: A healthy male volunteer and a mannequin head were each outfitted with a nasal continuous positive air pressure mask and pressure source (BiPAP S, Respironics, Murrysville, PA). Oxygen was added through either a side port in the mask or a port near the machine. Flow and FiO2 were measured while varying inspiratory and expiratory pressures. Measurements were repeated with a leak added to the system and using different sites of oxygen administration. Results: In both the human and in the model system, increasing inspiratory pressure, thereby increasing flow, decreased FiO2 inside the mask. In the model system, addition of a fixed leak caused an increase in flow and decrease in FiO2 at any given level of inspiratory and expiratory pressure. Conclusion: In patients using nasal positive pressure therapy, variables of pressure, leak around the mask, and the site of oxygen delivery determine the inspired oxygen concentration when giving oxygen supplementation.

REFERENCES

  • 1 Kita H, Ohi M, Chin K et al.. Effects of nasal continuous positive airway pressure therapy on respiratory parameters of upper airway patency in patients with obstructive sleep apnea syndrome.  Chest. 1998;  114 691-696
  • 2 Naughton M T. Pathophysiology and treatment of Cheyne-Stokes respiration.  Thorax. 1998;  53 514-518
  • 3 Resta O, Guido P, Picca V et al.. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study.  Respir Med. 1998;  92 820-827
  • 4 Schafer H, Ewig S, Hasper E, Luderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure.  Respir Med. 1998;  92 208-215
  • 5 Sampol G, Sagales M T, Roca A, de la Calzada M D, Bofill J M, Morell F. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease.  Eur Respir J. 1996;  9 111-116
  • 6 Teschler H, Stampa J, Ragette R, Konietzko N, Berthon-Jones M. Effect of mouth leak on effectiveness of nasal bilevel ventilatory assistance and sleep architecture.  Eur Respir J. 1999;  14 1251-1257

Elizabeth A YoderM.D. 

Internal Medicine Residency Program, University Hospitals of Cleveland

11100 Euclid Ave.

Cleveland, OH 44106

eMail: Beth.Yoder@att.net